Article Listing - Once-yearly Zometa increases bone density in osteoporosis

CYTOTHERAPEUTICS

10 February 1992

Thomas Wiggans has been named as chief operating officer of Cytotherapeutics.

SYNTHECELL

10 February 1992

John Byington becomes president of Synthecell and also of its wholly-owned subsidiary company, Genetic Medisyn.

NEOZYME CORP

10 February 1992

Greg Phelps is named as president of Neozyme Corporation. He replaces Elliott Hillback, who will remain a director.

UPJOHN'S HALCION

10 February 1992

Shareholders of the US pharmaceutical concern Upjohn (see also page 4) have filed a lawsuit which accuses the company's senior...

TANABE PHARMA IN FRANCE

10 February 1992

Japanese concern Tanabe Seiyaku has set up a subsidiary in Paris, France, to develop medical products. The subsidiary, which is...

UK DRUG STOCKS BULL RUN OVER?

10 February 1992

The performance of stocks in the UK's Health and Household sector, after a strong start to the New Year, came...

ICI PHARMA TACKLES GERMAN HEALTH FUNDS

10 February 1992

Imperial Chemical Industries' German pharmaceutical company, ICI Pharma, is preparing a legal offensive against the German health funds over drug...

ITALIAN DRUG SPENDING FORECASTS "ARE FOLLY"

10 February 1992

Federfarma, the Italian federation of pharmacists, disagrees with state estimates that the regional governments will pick up a bill of...

CIS PHARMA NEWS

10 February 1992

Bulgaria has said it may assist the republics of the Commonwealth of Independent States to develop their pharmaceutical industries,...

MERCK'S PROSCAR NEARING US APPROVAL

10 February 1992

With US Food and Drug Administration advisory panel recommendation of Merck & Co's Proscar (finasteride) last week, as an orally-active...

Showing 94781-94790 of 95329 articles

Go to beginningPreviousNextGo to end